stockportfolio.pro
Integra LifeSciences Holdings Corporation Revenue 2008–2025
Integra LifeSciences Holdings Corporation (IART) annual revenue by fiscal year, computed from SEC filings.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $1.64B | +1.5% |
| FY 2024 | $1.61B | +4.5% |
| FY 2023 | $1.54B | -1.0% |
| FY 2022 | $1.56B | +1.0% |
| FY 2021 | $1.54B | +12.4% |
| FY 2020 | $1.37B | -9.6% |
| FY 2019 | $1.52B | +3.1% |
| FY 2018 | $1.47B | +23.9% |
| FY 2017 | $1.19B | +19.8% |
| FY 2016 | $992.08M | — |
| FY 2015 | $0 | — |
| FY 2014 | $0 | — |
| FY 2013 | $0 | — |
| FY 2012 | $0 | — |
| FY 2011 | $0 | — |
| FY 2010 | $0 | — |
| FY 2009 | $0 | — |
| FY 2008 | $0 | — |
Source: Integra LifeSciences Holdings Corporation SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Integra LifeSciences Holdings Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeIntegra LifeSciences Holdings Corporation — frequently asked questions
What is Integra LifeSciences Holdings Corporation's revenue?
Integra LifeSciences Holdings Corporation (IART) reported revenue of $1.64B for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Integra LifeSciences Holdings Corporation's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.